Chemotherapy with or without bevacizumab should be the standard of care for first-line unresectable epithelioid mesothelioma
Fennell, Dean Dulloo, Sean
Fennell, Dean
Dulloo, Sean
Abstract
No abstract available.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022
Type
Article
Collections
Citation
Fennell, D. A., & Dulloo, S. (2022). Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 17(1), 34–37. https://doi.org/10.1016/j.jtho.2021.08.004